[1]
“Evaluation of Surrogate Risk Factors for Severe Progression of COVID-19 in Tobacco Smoking Sub-Population and its Possible Amelioration by Immune Modulators”, GJMR, vol. 22, no. K2, pp. 67–79, May 2022, Accessed: Jan. 30, 2026. [Online]. Available: https://medicalresearchjournal.org/index.php/GJMR/article/view/102185